Poly Medicure, 531768, POLYMED Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

22,865.16
70.51
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

22,830.64
0.13%
8.31

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.43
14.89
14.23

EBITDA CAGR (%)

10 Years
5 Years
3 Years

15.40
16.76
10.89

PAT CAGR (%)

10 Years
5 Years
3 Years

15.40
22.47
20.80

P:E (Median)

8 Years
5 Years
3 Years

49.68
60.61
61.91

P:BV (Average)

8 Years
5 Years
3 Years

8.16
9.05
9.26

EV:EBITDA (Average)

8 Years
5 Years
3 Years

28.81
35.68
39.81

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 26.92 33.94 43.37 54.32
P/E Ratio 99.99 79.31 62.06 49.55
Revenue 1366 1699 2084 2521
EBITDA 358 472 598 743
Net Income 258 340 435 545
ROA 15 13.6 12.7 13.5
P/B Ratio 17.57 14.71 9.32 7.53
ROE 19.05 15.3 14.53 15.94
FCFF -8.24 85.35 154.34 256.08
FCFF Yield -0.03 0.31 0.55 0.92

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 410.94 320.86 28.07% 402.47 319.90 25.81% 367.43 305.56 20.25% 360.93 293.31 23.05%
Expenses 295.34 236.46 24.90% 289.54 237.29 22.02% 266.23 220.46 20.76% 263.52 211.64 24.51%
EBITDA 115.60 84.40 36.97% 112.93 82.60 36.72% 101.20 85.10 18.92% 97.40 81.68 19.25%
EBIDTM 28.13% 26.30% 28.06% 25.82% 27.54% 27.85% 26.99% 27.85%
Other Income 21.75 16.57 31.26% 27.24 12.79 112.98% 16.83 13.17 27.79% 15.66 8.66 80.83%
Interest 3.13 3.35 -6.57% 3.13 2.10 49.05% 2.98 2.36 26.27% 2.93 2.21 32.58%
Depreciation 20.83 15.53 34.13% 20.11 15.33 31.18% 18.98 15.04 26.20% 16.16 14.71 9.86%
PBT 113.39 82.09 38.13% 116.93 77.96 49.99% 96.07 80.87 18.80% 93.97 73.40 28.02%
Tax 28.24 20.63 36.89% 29.71 18.76 58.37% 23.77 20.34 16.86% 23.44 15.92 47.24%
PAT 85.15 61.46 38.55% 87.22 59.20 47.33% 72.30 60.52 19.46% 70.53 57.48 22.70%
PATM 20.72% 19.15% 21.67% 18.51% 19.68% 19.81% 19.54% 19.60%
EPS 8.41 6.07 38.55% 8.61 5.84 47.43% 7.14 5.97 19.60% 6.96 5.67 22.75%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 424.21 339.60 24.91% 420.01 337.29 24.52% 384.78 320.83 19.93% 378.07 306.85 23.21%
Expenses 309.67 249.38 24.18% 304.69 253.06 20.40% 280.86 233.64 20.21% 281.50 223.64 25.87%
EBITDA 114.54 90.22 26.96% 115.33 84.23 36.92% 103.92 87.19 19.19% 96.58 83.21 16.07%
EBIDTM 27.00% 26.57% 27.46% 24.97% 27.01% 27.18% 25.55% 27.12%
Other Income 21.80 16.57 31.56% 26.10 14.09 85.24% 16.92 13.12 28.96% 14.97 8.49 76.33%
Interest 3.33 3.47 -4.03% 3.34 2.22 50.45% 3.16 2.49 26.91% 3.13 2.35 33.19%
Depreciation 21.51 16.21 32.70% 20.85 15.99 30.39% 19.65 15.53 26.53% 16.20 14.79 9.53%
PBT 111.51 87.11 28.01% 117.23 80.11 46.34% 98.02 82.29 19.12% 92.23 74.57 23.68%
Tax 28.00 22.81 22.75% 30.53 18.76 62.74% 24.42 20.34 20.06% 24.10 16.34 47.49%
PAT 83.51 64.30 29.88% 86.70 61.35 41.32% 73.60 61.95 18.81% 68.13 58.23 17.00%
PATM 19.69% 18.93% 20.64% 18.19% 19.13% 19.31% 18.02% 18.97%
EPS 8.41 6.78 24.04% 8.63 6.48 33.18% 7.71 6.53 18.07% 7.12 6.13 16.15%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,541.77 1,307.25 1,068.05 879.36 747.38 646.16 586.69 508.44 439.50 394.48 373.69 Net Sales Growth 24.37% 22.40% 21.46% 17.66% 15.66% 10.14% 15.39% 15.69% 11.41% 5.56% Cost Of Goods Sold 511.94 363.51 300.38 261.36 197.35 152.91 151.84 121.16 109.78 106.77 102.80 Gross Profit 1,029.83 943.73 767.66 618.00 550.03 493.25 434.84 387.28 329.72 287.71 270.89 GP Margin 66.80% 72.19% 71.87% 70.28% 73.59% 76.34% 74.12% 76.17% 75.02% 72.93% 72.49% Total Expenditure 1,114.63 955.63 801.67 665.47 537.03 483.92 452.71 386.94 345.39 308.04 289.10 Power & Fuel Cost - 43.09 37.33 28.98 24.58 24.73 24.16 18.45 16.17 14.53 12.51 % Of Sales - 3.30% 3.50% 3.30% 3.29% 3.83% 4.12% 3.63% 3.68% 3.68% 3.35% Employee Cost - 228.85 188.35 149.89 130.74 127.34 109.77 93.93 81.39 68.99 60.30 % Of Sales - 17.51% 17.63% 17.05% 17.49% 19.71% 18.71% 18.47% 18.52% 17.49% 16.14% Manufacturing Exp. - 232.04 205.63 171.34 137.77 127.95 120.38 112.90 96.71 85.08 83.33 % Of Sales - 17.75% 19.25% 19.48% 18.43% 19.80% 20.52% 22.21% 22.00% 21.57% 22.30% General & Admin Exp. - 44.41 36.54 29.22 27.09 30.46 27.25 19.63 19.97 15.09 12.82 % Of Sales - 3.40% 3.42% 3.32% 3.62% 4.71% 4.64% 3.86% 4.54% 3.83% 3.43% Selling & Distn. Exp. - 25.10 19.19 14.50 12.46 13.81 14.42 13.55 15.92 12.42 13.95 % Of Sales - 1.92% 1.80% 1.65% 1.67% 2.14% 2.46% 2.67% 3.62% 3.15% 3.73% Miscellaneous Exp. - 18.62 14.26 10.16 7.03 6.73 4.88 7.32 5.45 5.17 13.95 % Of Sales - 1.42% 1.34% 1.16% 0.94% 1.04% 0.83% 1.44% 1.24% 1.31% 0.90% EBITDA 427.13 351.62 266.38 213.89 210.35 162.24 133.98 121.50 94.11 86.44 84.59 EBITDA Margin 27.70% 26.90% 24.94% 24.32% 28.14% 25.11% 22.84% 23.90% 21.41% 21.91% 22.64% Other Income 81.48 58.18 36.29 38.73 19.29 18.58 16.05 14.37 13.53 8.38 8.22 Interest 12.17 12.85 10.19 5.36 9.95 19.76 13.18 11.11 8.42 9.76 10.18 Depreciation 76.08 62.05 55.64 52.54 46.31 39.28 36.36 28.41 22.96 20.19 18.09 PBT 420.36 334.89 236.83 194.72 173.38 121.78 100.49 96.36 76.26 64.88 64.54 Tax 105.16 83.17 57.78 48.70 43.87 29.40 34.21 26.16 20.06 17.57 23.10 Tax Rate 25.02% 24.84% 24.40% 25.01% 25.30% 24.14% 34.04% 27.15% 26.30% 27.08% 27.46% PAT 315.20 251.72 179.04 146.02 129.51 92.38 66.28 70.20 56.20 47.31 61.02 PAT before Minority Interest 315.20 251.72 179.04 146.02 129.51 92.38 66.28 70.20 56.20 47.31 61.02 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 20.44% 19.26% 16.76% 16.61% 17.33% 14.30% 11.30% 13.81% 12.79% 11.99% 16.33% PAT Growth 32.07% 40.59% 22.61% 12.75% 40.19% 39.38% -5.58% 24.91% 18.79% -22.47% EPS 31.12 24.85 17.67 14.41 12.78 9.12 6.54 6.93 5.55 4.67 6.02

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,607.07 1,375.80 1,115.23 923.06 786.47 687.24 610.83 520.42 455.01 412.26 390.35 Net Sales Growth 23.19% 23.36% 20.82% 17.37% 14.44% 12.51% 17.37% 14.38% 10.37% 5.61% Cost Of Goods Sold 538.49 393.31 321.72 281.60 212.45 170.01 164.86 124.64 116.82 114.12 110.64 Gross Profit 1,068.58 982.49 793.51 641.47 574.02 517.23 445.97 395.78 338.19 298.14 279.70 GP Margin 66.49% 71.41% 71.15% 69.49% 72.99% 75.26% 73.01% 76.05% 74.33% 72.32% 71.65% Total Expenditure 1,176.72 1,015.31 847.83 708.05 569.98 521.11 479.59 398.46 361.54 324.50 304.27 Power & Fuel Cost - 44.29 38.59 29.84 25.27 25.62 24.74 19.04 16.78 15.22 13.16 % Of Sales - 3.22% 3.46% 3.23% 3.21% 3.73% 4.05% 3.66% 3.69% 3.69% 3.37% Employee Cost - 245.91 202.75 163.62 141.76 138.76 116.61 99.13 87.26 74.77 64.99 % Of Sales - 17.87% 18.18% 17.73% 18.02% 20.19% 19.09% 19.05% 19.18% 18.14% 16.65% Manufacturing Exp. - 234.05 208.57 172.94 138.87 129.76 121.66 112.98 96.95 85.38 83.50 % Of Sales - 17.01% 18.70% 18.74% 17.66% 18.88% 19.92% 21.71% 21.31% 20.71% 21.39% General & Admin Exp. - 49.42 38.99 32.52 29.26 33.72 29.74 21.22 21.02 16.70 13.97 % Of Sales - 3.59% 3.50% 3.52% 3.72% 4.91% 4.87% 4.08% 4.62% 4.05% 3.58% Selling & Distn. Exp. - 27.25 20.99 15.68 13.80 15.37 15.89 13.98 17.02 12.88 14.28 % Of Sales - 1.98% 1.88% 1.70% 1.75% 2.24% 2.60% 2.69% 3.74% 3.12% 3.66% Miscellaneous Exp. - 21.08 16.23 11.86 8.57 7.87 6.10 7.48 5.70 5.42 14.28 % Of Sales - 1.53% 1.46% 1.28% 1.09% 1.15% 1.00% 1.44% 1.25% 1.31% 0.95% EBITDA 430.37 360.49 267.40 215.01 216.49 166.13 131.24 121.96 93.47 87.76 86.08 EBITDA Margin 26.78% 26.20% 23.98% 23.29% 27.53% 24.17% 21.49% 23.43% 20.54% 21.29% 22.05% Other Income 79.79 58.75 36.19 37.90 18.41 18.46 18.48 14.38 13.53 8.27 8.12 Interest 12.96 13.56 10.86 6.16 10.64 20.48 13.75 11.58 8.67 9.95 10.25 Depreciation 78.21 63.93 57.17 53.95 47.52 40.53 37.29 29.24 23.73 21.03 18.77 PBT 418.99 341.74 235.56 192.80 176.74 123.58 98.68 95.51 74.60 65.04 65.17 Tax 107.05 86.01 58.21 48.74 44.18 29.85 34.68 26.16 20.06 17.57 23.10 Tax Rate 25.55% 25.17% 24.71% 25.28% 25.00% 24.15% 35.14% 27.39% 26.89% 27.01% 27.26% PAT 311.94 258.26 179.28 146.51 135.87 93.74 64.00 69.35 54.54 47.47 61.65 PAT before Minority Interest 311.94 258.26 179.28 146.51 135.87 93.74 64.00 69.35 54.54 47.47 61.65 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.41% 18.77% 16.08% 15.87% 17.28% 13.64% 10.48% 13.33% 11.99% 11.51% 15.79% PAT Growth 26.89% 44.05% 22.37% 7.83% 44.94% 46.47% -7.71% 27.15% 14.89% -23.00% EPS 30.79 25.49 17.70 14.46 13.41 9.25 6.32 6.85 5.38 4.69 6.09

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,458.25 1,234.12 1,076.97 954.01 429.28 379.78 334.51 269.18 223.84 191.97 Share Capital 47.99 47.97 47.95 47.94 44.12 44.12 44.11 44.11 22.06 22.06 Total Reserves 1,406.86 1,183.85 1,027.50 905.28 385.02 335.36 289.98 224.83 201.78 169.91 Non-Current Liabilities 35.57 34.69 53.72 81.41 134.50 118.34 103.95 71.56 49.48 55.22 Secured Loans 1.09 11.56 30.56 59.74 110.57 91.38 79.12 47.62 31.06 40.25 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 4.20 3.09 2.86 2.31 2.91 2.48 2.10 3.33 2.57 2.04 Current Liabilities 400.35 326.81 203.27 195.54 208.27 162.44 116.18 108.13 102.97 107.26 Trade Payables 88.98 78.09 77.88 56.10 60.48 49.60 43.21 40.98 29.58 38.04 Other Current Liabilities 91.65 88.57 74.70 63.97 70.20 46.95 45.91 38.27 37.97 37.57 Short Term Borrowings 145.08 100.90 50.35 30.92 44.33 35.12 26.73 28.50 30.39 18.07 Short Term Provisions 74.64 59.25 0.35 44.55 33.26 30.77 0.33 0.38 5.03 13.58 Total Liabilities 1,894.17 1,595.62 1,333.96 1,230.96 772.05 660.56 554.64 448.87 376.29 354.45 Net Block 830.82 597.43 447.46 384.97 324.16 268.54 256.09 200.49 177.25 160.66 Gross Block 1,254.53 962.78 764.47 654.35 550.40 460.90 417.29 333.47 288.46 252.14 Accumulated Depreciation 423.71 365.35 317.02 269.39 226.24 192.36 161.20 132.98 111.21 91.48 Non Current Assets 1,029.57 782.49 592.97 513.73 446.65 351.83 304.82 248.78 212.85 203.16 Capital Work in Progress 70.71 77.74 42.97 21.18 24.58 18.53 18.25 20.00 13.72 9.80 Non Current Investment 81.07 56.96 46.94 39.80 45.49 45.55 11.19 6.25 5.61 5.61 Long Term Loans & Adv. 38.63 41.89 31.85 12.73 19.54 8.82 13.70 17.45 12.89 23.72 Other Non Current Assets 7.75 7.58 19.88 50.54 32.88 10.39 5.60 4.59 3.38 3.36 Current Assets 864.59 813.13 740.99 717.23 325.40 308.73 249.81 200.08 163.44 151.30 Current Investments 139.54 124.02 336.60 345.01 15.92 0.27 10.62 0.00 0.00 0.00 Inventories 193.01 182.80 150.24 109.38 100.96 74.12 68.55 57.91 40.58 53.87 Sundry Debtors 259.28 221.02 191.46 148.92 120.45 124.14 111.89 95.25 80.73 59.49 Cash & Bank 136.95 170.95 8.31 27.40 22.39 53.19 20.36 22.38 21.48 19.83 Other Current Assets 135.82 11.09 11.79 20.62 65.67 57.02 38.39 24.54 20.64 18.10 Short Term Loans & Adv. 119.70 103.25 42.60 65.88 52.93 36.17 16.46 10.23 11.67 8.97 Net Current Assets 464.25 486.32 537.72 521.69 117.13 146.29 133.64 91.96 60.46 44.04 Total Assets 1,894.16 1,595.62 1,333.96 1,230.96 772.05 660.56 554.63 448.86 376.29 354.46

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,470.05 1,241.63 1,087.48 965.57 434.82 381.37 338.30 271.54 228.63 196.18 Share Capital 47.99 47.97 47.95 47.94 44.12 44.12 44.11 44.11 22.06 22.06 Total Reserves 1,418.67 1,191.35 1,038.01 916.84 390.56 336.95 293.77 227.43 206.57 174.12 Non-Current Liabilities 37.38 42.28 62.68 86.76 139.23 118.99 103.95 71.56 49.48 55.22 Secured Loans 1.09 11.56 30.56 59.74 114.41 91.38 79.12 47.62 31.06 40.25 Unsecured Loans 0.00 5.94 7.56 3.54 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 5.99 4.60 3.98 3.27 3.80 3.13 2.10 3.33 2.57 2.04 Current Liabilities 424.61 351.17 226.68 215.10 225.49 181.24 122.58 113.85 109.25 112.62 Trade Payables 95.60 92.31 89.04 64.52 66.36 55.54 43.62 41.86 30.87 39.33 Other Current Liabilities 100.60 92.72 78.57 66.90 72.25 48.99 46.39 39.32 39.89 38.66 Short Term Borrowings 150.91 106.88 58.72 38.82 53.18 45.47 32.24 32.30 33.46 21.05 Short Term Provisions 77.50 59.25 0.35 44.86 33.71 31.24 0.33 0.38 5.03 13.58 Total Liabilities 1,932.04 1,635.08 1,376.84 1,267.43 799.54 681.60 564.83 456.95 387.36 364.02 Net Block 866.81 634.35 484.23 421.22 359.49 302.74 261.79 206.07 182.35 165.47 Gross Block 1,311.18 1,018.82 818.46 706.56 599.92 507.83 430.48 344.86 298.59 261.15 Accumulated Depreciation 444.38 384.47 334.23 285.34 240.42 205.09 168.69 138.79 116.24 95.68 Non Current Assets 1,017.05 770.52 593.40 519.62 449.54 352.28 309.62 252.03 216.76 204.51 Capital Work in Progress 75.71 78.16 43.40 21.21 24.71 19.42 18.25 20.00 13.72 9.80 Non Current Investment 27.57 7.64 9.77 9.40 12.92 10.79 10.28 3.92 4.42 3.95 Long Term Loans & Adv. 38.63 41.89 32.25 12.73 19.54 8.82 13.70 17.45 12.89 22.04 Other Non Current Assets 7.75 7.58 19.88 50.54 32.88 10.51 5.60 4.59 3.38 3.25 Current Assets 915.00 864.55 783.44 747.81 350.00 329.32 255.20 204.92 170.60 159.50 Current Investments 139.54 124.02 336.60 345.01 15.92 0.27 10.62 0.00 0.00 0.00 Inventories 221.03 208.65 168.36 126.48 112.09 83.79 72.99 61.95 46.00 57.62 Sundry Debtors 269.94 235.43 206.63 155.86 127.12 128.38 112.54 95.53 82.98 62.81 Cash & Bank 146.86 177.63 15.44 29.56 25.36 54.59 20.39 22.68 21.73 19.98 Other Current Assets 137.63 15.75 12.44 22.01 69.51 62.29 38.66 24.77 19.89 19.09 Short Term Loans & Adv. 120.73 103.06 43.98 68.88 56.20 40.83 16.65 10.29 10.97 9.73 Net Current Assets 490.39 513.38 556.76 532.71 124.51 148.08 132.63 91.07 61.35 46.88 Total Assets 1,932.05 1,635.07 1,376.84 1,267.43 799.54 681.60 564.82 456.95 387.36 364.01

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 256.10 196.83 126.26 116.40 126.91 113.19 75.50 55.02 61.88 63.28 PBT 334.89 236.83 194.72 173.38 121.78 100.49 96.36 76.26 64.88 64.54 Adjustment 35.82 60.17 38.60 44.94 50.36 40.93 37.78 21.89 24.89 41.23 Changes in Working Capital -40.87 -42.33 -60.19 -57.79 -9.66 -0.74 -35.50 -24.92 -14.00 -18.63 Cash after chg. in Working capital 329.84 254.67 173.13 160.54 162.49 140.68 98.63 73.23 75.77 87.14 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -73.74 -57.84 -46.86 -44.14 -35.58 -27.48 -23.14 -18.21 -13.89 -23.30 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.56 Cash From Investing Activity -237.02 -189.18 -88.71 -434.41 -105.67 -104.27 -87.07 -54.18 -30.25 -56.51 Net Fixed Assets -284.72 -233.08 -131.91 -100.55 -95.55 -43.89 -82.07 -51.29 -40.24 -48.59 Net Investments -39.63 202.56 1.27 -323.40 -15.59 -24.01 -15.56 -0.64 0.00 0.00 Others 87.33 -158.66 41.93 -10.46 5.47 -36.37 10.56 -2.25 9.99 -7.92 Cash from Financing Activity -17.32 -7.89 -39.71 318.92 -22.25 -9.69 14.48 -0.77 -30.66 -8.79 Net Cash Inflow / Outflow 1.76 -0.25 -2.16 0.90 -1.02 -0.77 2.91 0.07 0.96 -2.02 Opening Cash & Equivalents 0.38 0.63 2.79 1.89 2.91 3.68 0.77 0.70 11.71 13.73 Closing Cash & Equivalent 2.14 0.38 0.63 2.79 1.89 2.91 3.68 0.77 12.66 11.71

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 266.08 191.05 123.47 118.73 128.30 106.48 74.96 56.07 63.20 63.30 PBT 344.27 237.49 195.24 180.05 125.72 98.68 95.51 74.60 65.04 65.17 Adjustment 36.77 60.89 39.08 44.48 50.59 44.23 39.93 23.28 26.00 42.95 Changes in Working Capital -40.66 -49.46 -63.39 -61.19 -12.07 -8.69 -37.35 -23.60 -13.95 -20.96 Cash after chg. in Working capital 340.38 248.92 170.93 163.35 164.24 134.21 98.09 74.28 77.09 87.17 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -74.30 -57.87 -47.46 -44.62 -35.93 -27.72 -23.14 -18.21 -13.89 -23.30 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -240.94 -179.24 -85.33 -435.58 -107.26 -100.74 -88.03 -55.67 -31.38 -59.33 Net Fixed Assets -284.72 -233.08 -131.91 -100.55 -95.55 -43.89 -82.07 -51.29 -40.24 -48.59 Net Investments -39.63 202.56 1.27 -323.40 -15.59 -24.01 -15.56 -0.64 0.00 0.00 Others 83.41 -148.72 45.31 -11.63 3.88 -32.84 9.60 -3.74 8.86 -10.74 Cash from Financing Activity -20.15 -12.51 -35.34 316.95 -20.51 -5.13 15.71 -0.28 -30.77 -5.89 Net Cash Inflow / Outflow 4.99 -0.70 2.80 0.10 0.54 0.62 2.64 0.11 1.06 -1.91 Opening Cash & Equivalents 7.06 7.76 4.95 4.86 4.32 3.70 1.06 0.95 11.86 13.77 Closing Cash & Equivalent 12.05 7.06 7.76 4.95 4.86 4.32 3.70 1.06 12.91 11.86

Financial Ratios

Consolidated /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 151.59 128.39 112.14 99.42 48.63 43.01 37.87 30.48 25.37 21.76 ROA 14.43% 12.22% 11.39% 12.93% 12.90% 10.91% 13.99% 13.62% 12.95% 19.16% ROE 18.74% 15.52% 14.40% 18.74% 22.85% 18.58% 23.28% 22.81% 22.75% 36.34% ROCE 23.28% 19.34% 17.68% 21.62% 24.64% 22.92% 25.96% 25.30% 26.14% 39.37% Fixed Asset Turnover 1.18 1.24 1.24 1.25 1.28 1.34 1.36 1.44 1.48 1.70 Receivable days 66.78 70.18 70.30 65.44 69.08 73.42 74.17 71.95 63.95 50.66 Inventory Days 52.25 56.67 53.62 51.10 49.45 44.38 45.28 40.27 43.08 45.05 Payable days 83.88 94.76 93.55 107.80 40.28 37.08 39.12 37.36 39.89 41.92 Cash Conversion Cycle 35.16 32.09 30.37 8.73 78.25 80.72 80.33 74.86 67.14 53.79 Total Debt/Equity 0.11 0.11 0.10 0.13 0.44 0.40 0.38 0.36 0.35 0.40 Interest Cover 27.06 24.23 37.30 18.43 7.16 8.63 9.67 10.06 7.65 9.26

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 152.82 129.17 113.24 100.62 49.26 43.19 38.30 30.78 25.91 22.24 ROA 14.48% 11.90% 11.08% 13.15% 12.66% 10.27% 13.58% 12.92% 12.64% 18.97% ROE 19.09% 15.42% 14.29% 19.42% 22.98% 17.80% 22.76% 21.81% 22.35% 36.03% ROCE 23.63% 19.10% 17.42% 21.96% 24.43% 22.19% 25.39% 24.37% 25.59% 38.90% Fixed Asset Turnover 1.19 1.22 1.22 1.21 1.24 1.30 1.35 1.44 1.49 1.71 Receivable days 66.78 72.05 71.34 65.34 67.85 71.98 72.79 70.54 63.66 50.14 Inventory Days 56.78 61.45 58.03 55.09 52.02 46.84 47.20 42.65 45.25 46.02 Payable days 87.19 102.88 99.52 112.43 41.75 38.03 38.55 36.95 39.11 41.04 Cash Conversion Cycle 36.37 30.62 29.84 8.01 78.12 80.80 81.45 76.24 69.80 55.12 Total Debt/Equity 0.12 0.12 0.12 0.14 0.47 0.42 0.39 0.37 0.36 0.40 Interest Cover 26.38 22.87 32.68 17.92 7.04 8.18 9.25 9.61 7.54 9.27

Top Investors:

quant mutual fund - quant large cap fund

nirmala vinodkumar daga

max life insurance co ltd a/c nifty momentum quality 50 fund

uti - healthcare fund

smallcap world fund, inc

varun daga

shreans daga

lighthouse india fund iv aif

Annual Reports:

News Update:

Poly Medicure receives MDR certification for 54 products
11th Mar 2025, 16:41 PM

The MDR certification reaffirms that these products meet the highest safety, quality, and regulatory standards set by the European Union
Read More
Poly Medicure incorporates wholly owned Step-down subsidiary
6th Feb 2025, 09:14 AM

The prime focus is to help the Poly Medicure to diverse and expand its geographical presence
Read More
Poly Medicure - Quarterly Results
3rd Feb 2025, 14:30 PM

Read More

Poly Medicure Ltd.

Medical Equipment/Supplies/Accessories

BSE: 531768 | NSE: POLYMED

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Poly Medicure Ltd.

Medical Equipment/Supplies/Accessories

BSE: 531768 | NSE: POLYMED

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: